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CASE PRESENTATION
A 50-year-old white male on chronic maintenance
hemodialysis was evaluated for abdominal pain and
urinary hesitancy. He developed end-stage kidney disease
as a complication of hypertension and renovascular
disease and had been on peritoneal dialysis for 3.5 years.
He was well until 3 weeks earlier, when he developed
methicillin-resistant Staphylococcus aureus peritonitis with
a tunnel abscess that required catheter removal and
transition to hemodialysis. He improved clinically and was
discharged from the hospital 1 week earlier. At the time of
consultation, he complained of a new periumbilical pain
that extended to the suprapubic area. It had been present
for 2 days and was different from the pain experienced as
a result of his recent episode of peritonitis. It was
accompanied by nausea, vomiting, constipation (owing to
narcotics), and urinary hesitancy without frequency or
dysuria. His urine output was approximately 500 ml/day.
His medical history was significant for hypertension,
atherosclerotic renovascular disease, and congestive heart
failure. He had never had a urinary tract infection in the
past. Medications included oxycodone, lisinopril, atenolol,
sevelamer, a multivitamin preparation, folic acid, darbe-
poietin, paricalcitol, and heparin. On examination, he was
afebrile and in no acute distress. His abdominal exam
showed a well-healed scar at the site of Tenkhoff catheter
removal, normal bowel sounds, and mild periumbilical
and suprapubic tenderness without guarding or rebound.
The remainder of the examination was unremarkable
other than for the presence of a tunneled hemodialysis
catheter on the right internal jugular vein. Routine serum
chemistries including liver function tests and pancreatic
enzymes were unremarkable. His leukocyte count was
8200 cells/mm3. A flat plate of the abdomen showed large
amounts of stool but no other abnormalities. The urine
dipstick showed 1þ protein, 1þ hemoglobin, 1þ
leukocyte esterase, and negative nitrite. Microscopicex-
amination disclosed 8–12 leukocytes per high-power field
(hpf), 10 red blood cells per hpf, and no bacteria. He had
only two other urinalysis in our database, both obtained
approximately four years earlier. On both occasions he
had 3þ protein and microhematuria (5–40 cells/hpf), but
no pyuria. A urine culture yielded no growth. His
treatment focused on his constipation and his abdominal
pain resolved over the ensuing week. We repeated a
urinalysis 10 weeks later, at a time when he had been
asymptomatic for more than 2 months; it contained
65 white blood cells/hpf, 10 red cells per hpf, and trace
bacteria. A urine culture was again negative.
DISCUSSION
Dialysis patients are more susceptible to urinary tract
infections (UTI), and UTIs are an important cause of
morbidity and mortality in these patients.1–3 When undiag-
nosed and untreated, significant complications may occur,
leading to the need for drainage procedures, nephrectomy, or
death.1 Delayed diagnosis is a relevant issue because the
urinary tract is often overlooked as a source of infection in
dialysis patients, especially because UTI symptoms are mostly
related to voiding, which is reduced or absent in these
patients. When diagnosed in a timely manner, these
infections are easily treatable,4 and early treatment prevents
future complications. The question at hand in this case is the
value of pyuria as a marker of UTI in patients on dialysis.
This question is often raised because of several clinical factors
that may confound this relationship, and the observations of
some authors that the presence of pyuria in dialysis patients
is not indicative of infection.5,6 Confounding factors include
the presence of low urine volume, bladder stasis, and the
underlying etiology of kidney disease, as many conditions
leading to terminal kidney failure are associated with sterile
pyuria owing to chronic parenchymal inflammation. Even
though the latter is predominantly lymphocytic – not
neutrophylic as in cases of bacterial infections – this
distinction is not routinely made in clinical laboratories. In
this discussion, we will review the current definition of
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pyuria and the available literature on its relationship to UTI
in patients on chronic maintenance dialysis.
Pyuria as a predictor of UTI in the general population
A healthy individual may excrete up to 400 000 white blood
cells per hour in urine.7 At an average flow rate of 60 ml/h, this
works out to o10 white blood cells/microliter of urine. In
routine testing, pyuria is analyzed through different methods;
the most popular is counting cells in sedimented urine. For
this test, the normal limit is o5 white blood cells per high-
power field (hpf).7 Stamm considers this method unreliable,
not correlating to the gold standard (leukocyte excretion rate
in timed urine collections) in up to 40% of the cases.3 The
reasons for this limited reliability relate to variables such as
time of centrifugation, number of rotations of the centrifuge,
initial urine volume, the amount of volume of resuspension
after centrifugation, observer bias (tendency to count in areas
of higher number of cells), limited counting accuracy when
gridlines are not used, and the observation that centrifugation
causes a variable and unpredictable loss of leukocytes.3 Thus,
hemocytometry of the uncentrifuged urine using an auto-
mated device has been recommended as the method of choice,
as it is faster and possibly more accurate than manual
examination of the centrifuged sediment.3 There are several
available technologies for this assessment, including counting
chambers, image analysis with automated particle recognition,
and flow cytometry.3,8,9 It is unclear, however, that automated
urinalysis is more accurate in the diagnosis of UTI.10,11 In fact,
many of the studies validating these technologies used manual
counts of the centrifuged urine as the gold standard.8,12,13 It is
our impression that, while remaining mindful of the
limitations and variability of the manual examination, it is
not unreasonable to continue to accept it in clinical practice.
The predictive value for a positive urine culture for each of the
methods is summarized in Table 1.
Virtually every disease of the urinary tract may cause
pyuria. In patients without kidney disease, it has value in the
assessment of UTIs for both diagnosis and follow-up. It is
present in nearly every patient with symptoms of UTI and
bacteriuria, and in almost none without these two entities.3
In patients with asymptomatic bacteriuria, it helps to differ-
entiate between true infection and transient colonization, and
in symptomatic non-bacteriuric patients, it may indicate
infection by unusual pathogens that do not grow in usual
cultures, simulating aseptic pyuria.3
In summary, the presence of pyuria in patients without
kidney disease is highly suggestive of UTI, especially in
symptomatic patients.
Diagnostic value of pyuria in dialysis patients
In patients with chronic kidney disease, especially those on
dialysis, the role of pyuria in the diagnosis of UTI is
uncertain. Cabaluna et al.5 were the first to explore the
occurrence of pyuria in dialysis patients. In their study of 25
chronic hemodialysis patients, they showed that pyuria is a
common finding that often occurs in the absence of
infection. Unfortunately, the interpretation of their results
is difficult, as pyuria was defined on a scale of ‘white cell
clumps’, which was not precisely defined. Of interest,
nonetheless, was the observation that pyuria was predomi-
nantly lymphocytic and developed only after progression to
end-stage disease requiring dialysis. In fact, the authors
reported that patients uniformly ‘progressed’ to this pattern
of sterile pyuria. Therefore, this paper is relevant in that it
demonstrated that urine may lose characteristics of the
original pathology after the initiation of dialysis.
Other investigators have explored the problem in follow-
up to Cabaluna’s observations – Table 2 summarizes the
characteristics of available studies and the performance of
leukocyturia as an indicator of UTI in dialysis subjects. The
prevalence of pyuria in dialysis patients ranges between 28
and 72%. The prevalence of documented UTI in these studies
varied between 11 and 70%. Data in Table 2 make it readily
apparent that the sample size of most studies is small and
the operating characteristics of the test (when calculable)
are variable. The most consistent observation is pyuria’s
high negative predictive value for UTI. Because of the lower
specificity caused by the occurrence of sterile pyuria in
several of the causes of chronic kidney disease, the positive
predictive value of pyuria is noticeably lower. Therefore, the
absence of pyuria in an asymptomatic patient speaks strongly
against the presence of infection, although it should not be
relied upon in symptomatic patients, in whom a urine
culture must be obtained;14 its presence, while common,
demands a urine culture as it is often unrelated to infection
in dialysis patients.
Saitoh et al.15 suggested that pyuria is not a good marker
for UTI in oliguric patients, as it held a negative correlation
with urinary volume, a finding that was recently corroborated
by Hyodo et al.16 in 75 asymptomatic hemodialysis patients
Table 1 | Characteristics of the different methods to assess pyuria in clinical specimens
Method Comments
Dipstick leukocyte esterase Detection threshold equivalent to B5 WBC/hpf. PPV for UTI is 47%, NPV is 94%. Not studied in dialysis patients.




Normal range o5 WBC/hpf. Reproducibility and interobserver agreement are limited. PPV for UTI is 46%, NPV is 96%.
hpf, high-power field; NPV, negative predictive value; PPV, positive predictive value; UTI, urinary tract infection; WBC, white blood cells.
Diagnostic estimates from Wallach19 and Stamm.3
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using bacteriuria as the end point. The prevalence of pyuria
tracked well with the prevalence of bacteriuria across strata of
urine output. Leukocyturia was detected in 26 of 39 (66%)
patients with urine output o200 ml/day and in three of 19
(16%) of those with urine output 4500 ml/day. Rates of
bacteriuria were 59 and 21%, respectively. Despite the fact
that this finding was not replicated in a third study,17 it is
plausible that low urine volume is an important factor
leading to the high prevalence of pyuria in dialysis patients,
and it is reasonable to take this factor into account when
interpreting pyuria in individual dialysis patients.
While several studies raised the impression that pyuria is
not an accurate marker of infection,5,6,15 other investigators
have defended pyuria as an important marker for UTI in
dialysis patients.17,18 Orlowska et al.18 analyzed 43 asympto-
matic patients on continuous ambulatory peritoneal dialysis,
and demonstrated that pyuria was present in 67% of patients
with UTI and only 13% of patients with negative urine
culture. In a well-designed study, Chaudhry et al.17 evaluated
pyuria in 32 asymptomatic hemodialysis patients who gave
two separate urine specimens on two different occasions. Of
10 patients with pyuria, seven had positive cultures, two had
renal tuberculosis as the underlying diagnosis, and only one
had unexplained sterile pyuria. Conversely, only two of the 22
patients without pyuria had a positive urine culture. Both of
these groups of investigators concluded that pyuria is a good
marker for UTI in this population.
As illustrated in our case, the presence of pyuria does not
always indicate the presence of infection. However, it is our
impression that the available data justify formal evaluation of
pyuria with a urine culture, as there is excessive variability in
the coexistence of UTI (11–70%).6,15,17,18 On the other hand,
the absence of pyuria in asymptomatic patients is highly
predictive of the absence of infection (Table 2). In the general
population, patients who have lower urinary symptoms or
who are at risk of infection, a urine culture must be
performed to rule out infection.14 There are no studies
addressing the diagnostic value of pyuria in dialysis patients
with UTI symptoms.
Urine dipsticks for nitrite and leukocyte esterase are often
used in clinical practice to rule out UTI (Table 1). We were
unable to find any studies of these methods in dialysis
patients.
The foregoing discussion makes evident the limitations
of the available literature. We were unable to locate studies
with enough statistical power to generate evidence with
high quality to unequivocally guide clinical practice.
Other shortcomings also apply. For example, most studies
included a single urine specimen rather than a longitudinal
follow-up at multiple times. In addition, the cutoff for
pyuria used in most studies was 10 cell/hpf, which is higher
than current standards (X5 cells/hpf);7 thus, it is
possible that the operating characteristics of pyuria are
different when using the current cutoffs. Besides, the
predominant use of cell counts rather than hemocytometry
may have introduced biases in the results of available studies.
However, because hemocytometry is not routinely used in
most laboratories, this limitation does not detract from
the generalizability of these data. In our opinion, the best
available evidence indicates that pyuria is an acceptable
marker for UTI in dialysis patients, the most probable
confounding factor being urine volume. A large, prospective
study with long-term follow-up using serial urinalyses
and urine cultures to determine the clinical significance of
this finding would address many of these limitations
and would be an important contribution to the care of
patients on dialysis.
PERSPECTIVE
Our review identified a small body of literature that has
significant limitations. Despite this caveat, we believe the
following conclusions are applicable:
1. The presence of pyuria is common (30–40%) but not the
rule in patients on dialysis.
Table 2 | Characteristics of studies evaluating pyuria in patients on dialysis
Author
(ref. no.) N Method Cutoff
Prevalence
(%) Diagnostic remarks
Cabaluna5 25 N/A N/A 72–100a Cannot be calculated. Authors concluded that pyuria and WBC
casts are the rule in dialysis patients
Saitoh15 90 of 182b CC X10 38 Se 82%, Sp 99%, PPV 99%, NPV 87%b
Chaudry17 32 CC X10 31 Se 88%, Sp 88%, PPV 70%, NPV 96%
Eisinger6 28 CC X10 32 Se 50%, Sp 69%, PPV 11%, NPV 95%
Orlowska18 43 CC X10 28 Se 67%, Sp 87%, PPV 67%, NPV 87%
Hyodo16 75 HC X10 45 Cannot be calculated because the frequency of urinary tract
infection was not studied. Authors noted higher prevalence of
pyuria and bacteriuria in patients with lower urine volume.
CC, cell count (manual); HC, hemocytometry (automated); N=sample size; N/A, not applicable; NPV, negative predictive value; PPV, positive predictive value; Se, sensitivity;
Sp, specificity; WBC, white blood cells.
AOut of 25, 18 had ‘clumps of white cells,’ all patients had white cell casts.
bNinety hemodialysis patients among 182 patients with chronic kidney disease. Diagnostic remarks refer to the entire sample (no separate data presented for dialysis
patients).
Method.
Cutoff, number of white blood cells considered abnormal.
Prevalence, prevalence of pyuria in the study population.
All refer to the ability to diagnose urinary tract infection based on urine cultures.
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2. Infection is uncommon in the absence of pyuria
(5–10%).
3. When pyuria is present, the coexistence of a UTI is highly
variable in this population (11–70%)
4. Given the above, it is our impression that the presence of
pyuria in dialysis patients demands the performance of a
urine culture.
REFERENCES
1. Lees JA, Falk RM, Stone WJ et al. Pyocystis, pyonephrosis and perinephric
abscess in end stage renal disease. J Urol 1985; 134: 716–719.
2. Rault R. Symptomatic urinary tract infections in patients on maintenance
hemodialysis. Nephron 1984; 37: 82–84.
3. Stamm WE. Measurement of pyuria and its relation to bacteriuria. Am J
Med 1983; 75: 53–58.
4. Bennett WM, Craven R. Urinary tract infections in patients with severe
renal disease. Treatment with ampicillin and trimethoprim-sulfamethox-
azole. JAMA 1976; 236: 946–948.
5. Cabaluna CC, Gary NE, Eisinger RP. Urinalysis in patients on chronic
hemodialysis. Urology 1977; 10: 103–104.
6. Eisinger RP, Asghar F, Kolasa C et al. Does pyuria indicate infection in
asymptomatic dialysis patients? Clin Nephrol 1997; 47: 50–51.
7. Kim SM, Corwin HL. Urinalysis. In: Schrier RW (ed). Diseases of the Kidney,
7th edn. Lippincott Williams & Wilkins: Philadelphia, 2001, pp 317–331.
8. Okada H, Sakai Y, Kawabata G et al. Automated urinalysis. Evaluation of
the Sysmex UF-50. Am J Clin Pathol 2001; 115: 605–610.
9. Wah DT, Wises PK, Butch AW. Analytic performance of the iQ200
automated urine microscopy analyzer and comparison with manual
counts using Fuchs–Rosenthal cell chambers. Am J Clin Pathol 2005; 123:
290–296.
10. Regeniter A, Haenni V, Risch L et al. Urine analysis performed by flow
cytometry: reference range determination and comparison to morpho-
logical findings, dipstick chemistry and bacterial culture results – a
multicenter study. Clin Nephrol 2001; 55: 384–392.
11. Zaman Z, Roggeman S, Verhaegen J. Unsatisfactory performance of flow
cytometer UF-100 and urine strips in predicting outcome of urine
cultures. J Clin Microbiol 2001; 39: 4169–4171.
12. Ben-Ezra J, Bork L, McPherson RA. Evaluation of the Sysmex UF-100
automated urinalysis analyzer. Clin Chem 1998; 44: 92–95.
13. Koken T, Aktepe OC, Serteser M et al. Determination of cut-off values for
leucocytes and bacteria for urine flow cytometer (UF-100) in urinary tract
infections. Int Urol Nephrol 2002; 34: 175–178.
14. Nicolle LE. Asymptomatic bacteriuria: when to screen and when to treat.
Infect Dis Clin N Am 2003; 17: 367–394.
15. Saitoh H, Nakamura K, Hida M et al. Urinary tract infection in oliguric
patients with chronic renal failure. J Urol 1985; 133: 990–993.
16. Hyodo T, Yoshida K, Sakai T et al. Asymptomatic hyperleukocyturia in
hemodialysis patients analyzed by the automated urinary flow cytometer.
Ther Apher Dial 2005; 9: 402–406.
17. Chaudhry A, Stone WJ, Breyer JA. Occurrence of pyuria and bacteriuria in
asymptomatic hemodialysis patients. Am J Kidney Dis 1993; 21: 180–183.
18. Orlowska A, Majdan M, Koziol-Montewka M et al. Asymptomatic
bacteriuria in patients on continuous ambulatory peritoneal dialysis. Ann
Univ Mariae Curie Sklodowska (Med) 2002; 57: 285–289.
19. Wallach J. Interpretation of Diagnostic Tests, 5th edn. Little, Brown and
Company: Boston, MA, 1992.
2038 Kidney International (2006) 70, 2035–2038
t h e r e n a l c o n s u l t LR Fasolo et al.: Pyuria in dialysis patients
